FDA recalls extended-release metformin | 4 cardiac arrhythmias associated with COVID-19 | When volumes should normalize

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU. 

Cardiology may return to pre-COVID-19 volumes sooner than many other healthcare specialties. What does this mean for hospitals throughout the United States?  

TAVR is a safe, effective treatment for patients with bicuspid valves, according to research published in JACC: Cardiovascular Interventions.

Eugene “Gene” J. Sayfie, MD, a veteran cardiologist from Miami, died from COVID-19-related complications on May 23. He was 85 years old.

When patients with coronary in-stent restenosis (ISR) require reintervention, should specialists turn to drug-coated balloon (DCB) angioplasty or a drug-eluting stent (DES)?

Tauvid was developed by Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, and offers clinicians a new type of brain scan to use in patients being evaluated for Alzheimer's disease.

CVS Health has been accused of overcharging for generic medications in a new lawsuit brought forth by six Blue Cross Blue Shield plans.